Isemid Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

isemid

ceva santé animale - torasemide - Висок таван диуретици, сулфонамиди, обикновена - Кучета - За лечение на клинични признаци, свързани със застойна сърдечна недостатъчност при кучета, включително оток на белите дробове.

Cufence Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

cufence

univar solutions bv - триентин дихидрохлорид - Хепатолентикуларна дегенерация - Други стомашно-чревния тракт и обмяната на веществата средства, - cufence е показан за лечение на болестта на Уилсън при пациенти с непоносимост към d-пеницилламин терапия при възрастни и деца на възраст под 5 години и над.

Sunosi Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

sunosi

atnahs pharma netherlands b.v. - solriamfetol хидрохлорид - narcolepsy; sleep apnea, obstructive - psychoanaleptics, - sunosi е показан за подобряване на будност и намаляване на прекомерна сънливост през деня и при възрастни пациенти с нарколепсия (С или без катаплексията). sunosi е показан за подобряване на будност и намаляване на прекомерна сънливост през деня (eds) при възрастни пациенти със синдром на обструктивна сънна апнея (osa), които ЭЦП е достатъчно обработени първични Оса терапия, като постоянно положително налягане в дихателните пътища (СРАР).

Lumeblue (previously known as Methylthioninium chloride Cosmo) Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - метилтионинов хлорид - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Thiotepa Riemser Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - тиотепа - hematopoietic stem cell transplantation; neoplasms - Антинеопластични средства - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Efmody Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

efmody

diurnal europe b.v. - хидрокортизон - adrenal hyperplasia, congenital - Кортикостероиди за системна употреба - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.

Amifampridine SERB Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

amifampridine serb

serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - Други лекарства в нервната система - Симптоматично лечение на миастенен синдром на lambert-eaton (lems) при възрастни.

Dapagliflozin Viatris Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - Лекарства, използвани при диабет - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 и 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Ztalmy Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

ztalmy

marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - Други противоэпилептические средства - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.

Qaialdo Kesatuan Eropah - Bulgaria - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - спиронолактон - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 и 5.